Major Depression
-
{
- All
- News
-
Mental Illness Burden Nearly Doubles Globally Since 1990, Says New Lancet Study
The findings suggest that mental health problems are no longer a secondary issue but a major global concern affecting productivity, education and overall quality of life.
-
Mental Illness Burden Nearly Doubles Globally Since 1990, Says New Lancet Study
The findings suggest that mental health problems are no longer a secondary issue but a major global concern affecting productivity, education and overall quality of life.
-
Cipla Gets US Regulator's Nod For Generic Antidepressant
Drug firm Cipla on Tuesday said its US arm InvaGen Pharmaceuticals Inc has received a final approval from the US Food and Drug Administration (FDA) to market generic Bupropion Hydrochloride extended release tablets used for treatment of major depressive disorder.
-
Mental Health: What Is Major Depressive Disorder? Signs, Causes, Treatment & Prevention
MDD is a complex disorder that can be caused by a combination of genetic, biological, environmental, and psychological factors. Let's understand it in depth.
-
What Is Major Depressive Disorder (MDD)? Everything You Need To Know
Persistent and intense feelings of sadness for an extended period of time can increase your risk of major depressive disorder (MDD). Here's what you need to know about it.
-
What Is Major Depressive Disorder (MDD)? Everything You Need To Know
Persistent and intense feelings of sadness for an extended period of time can increase your risk of major depressive disorder (MDD). Here's what you need to know about it.
-
Cipla Gets US Regulator's Nod For Generic Antidepressant
Drug firm Cipla on Tuesday said its US arm InvaGen Pharmaceuticals Inc has received a final approval from the US Food and Drug Administration (FDA) to market generic Bupropion Hydrochloride extended release tablets used for treatment of major depressive disorder.
-
Suven Life Sciences Gets Patent Rights For 2 Drugs; Shares Rally 5%
Suven Life Sciences shares rallied as much as 5 per cent to hit intra-day high of Rs 275.20, after the company declared it had received patent rights from Europe and Macau for two drugs used in the treatment of disorders associated with neurodegenerative diseases.
-
Depression weakens bones
People who suffer from major depression are at risk for low bone mineral density (BMD).
-
Mental Illness Burden Nearly Doubles Globally Since 1990, Says New Lancet Study
The findings suggest that mental health problems are no longer a secondary issue but a major global concern affecting productivity, education and overall quality of life.
-
Mental Illness Burden Nearly Doubles Globally Since 1990, Says New Lancet Study
The findings suggest that mental health problems are no longer a secondary issue but a major global concern affecting productivity, education and overall quality of life.
-
Cipla Gets US Regulator's Nod For Generic Antidepressant
Drug firm Cipla on Tuesday said its US arm InvaGen Pharmaceuticals Inc has received a final approval from the US Food and Drug Administration (FDA) to market generic Bupropion Hydrochloride extended release tablets used for treatment of major depressive disorder.
-
Mental Health: What Is Major Depressive Disorder? Signs, Causes, Treatment & Prevention
MDD is a complex disorder that can be caused by a combination of genetic, biological, environmental, and psychological factors. Let's understand it in depth.
-
What Is Major Depressive Disorder (MDD)? Everything You Need To Know
Persistent and intense feelings of sadness for an extended period of time can increase your risk of major depressive disorder (MDD). Here's what you need to know about it.
-
What Is Major Depressive Disorder (MDD)? Everything You Need To Know
Persistent and intense feelings of sadness for an extended period of time can increase your risk of major depressive disorder (MDD). Here's what you need to know about it.
-
Cipla Gets US Regulator's Nod For Generic Antidepressant
Drug firm Cipla on Tuesday said its US arm InvaGen Pharmaceuticals Inc has received a final approval from the US Food and Drug Administration (FDA) to market generic Bupropion Hydrochloride extended release tablets used for treatment of major depressive disorder.
-
Suven Life Sciences Gets Patent Rights For 2 Drugs; Shares Rally 5%
Suven Life Sciences shares rallied as much as 5 per cent to hit intra-day high of Rs 275.20, after the company declared it had received patent rights from Europe and Macau for two drugs used in the treatment of disorders associated with neurodegenerative diseases.
-
Depression weakens bones
People who suffer from major depression are at risk for low bone mineral density (BMD).
